Carnitine deficiency syndromes.
Carnitine deficiency syndromes manifest as metabolic encephalopathy, lipid storage myopathy, or cardiomyopathy. Impairment of long-chain fatty acid metabolism and failure of energy production affect tissues reliant on oxidative metabolism. The accumulation of toxic fatty acyl derivatives impedes gluconeogenesis and urea cycle function which, in turn, causes hypoketotic hypoglycemia, transaminase elevations, and hyperammonemia. Oxidation of accumulated fatty acids through an alternative pathway, omega-oxidation, produces dicarboxylic aciduria. Carnitine must be transported into skeletal muscle. Myopathic carnitine deficiency occurs when this transport mechanism is defective. Most systemic carnitine deficiencies are secondary to other disorders that promote excretion of carnitine as acylcarnitine; however, primary systemic carnitine deficiency, likely due to impaired renal conservation of carnitine, also occurs.
Breningstall
G N
GN
Department of Pediatrics, Park Nicollet Medical Center, Minneapolis, Minnesota.
D002331:Carnitine / Q000172:deficiency* / Q000378:metabolism; D006801:Humans; D008659:Metabolic Diseases / Q000503:physiopathology*; D009135:Muscular Diseases / Q000378:metabolism*; D013577:Syndrome
D002331:Carnitine